We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Wheaton Precious Metals
WPM
$59.9B
| $3.84M | ﹤0.01% |
32,646
+17,957
| +122% | +$1.92M |
|
1477
CALL
CytomX Therapeutics
CTMX
$730M
| $3.83M | ﹤0.01% |
900,000
| – | – |
|
|
DMC
1478
Del Monte Corp
DMC
$1.44B
| $3.82M | ﹤0.01% |
+107,276
| New | +$3.83M |
|
|
ECG
1479
Everus Construction Group
ECG
$7.02B
| $3.82M | ﹤0.01% |
+44,607
| New | +$3.99M |
|
|
JOYY
1480
JOYY Inc
JOYY
$3.64B
| $3.79M | ﹤0.01% |
58,456
+43,761
| +298% | +$2.67M |
|
1481
Xenon Pharmaceuticals
XENE
$6.21B
| $3.78M | ﹤0.01% |
84,360
-238,096
| -74% | -$10M |
|
|
MBX
1482
MBX Biosciences
MBX
$3.23B
| $3.78M | ﹤0.01% |
119,726
+94,085
| +367% | +$2.28M |
|
1483
Capital One
COF
$137B
| $3.77M | ﹤0.01% |
15,569
-290,967
| -95% | -$64.8M |
|
1484
Intel
INTC
$527B
| $3.77M | ﹤0.01% |
102,194
-378,516
| -79% | -$14.3M |
|
1485
Edgewise Therapeutics
EWTX
$4.69B
| $3.77M | ﹤0.01% |
+151,905
| New | +$3.05M |
|
1486
Par Pacific Holdings
PARR
$4.12B
| $3.77M | ﹤0.01% |
107,218
-275,440
| -72% | -$10.9M |
|
1487
Zillow
Z
$8.08B
| $3.76M | ﹤0.01% |
55,150
-137,952
| -71% | -$9.99M |
|
|
MOFG
1488
DELISTED
MidWestOne Financial Group
MOFG
| $3.75M | ﹤0.01% |
+97,481
| New | +$3.55M |
|
1489
Alpha Teknova
TKNO
$396M
| $3.75M | ﹤0.01% |
987,197
-29
| -0% | -$141 |
|
1490
PUT
Gilead Sciences
GILD
$171B
| $3.74M | ﹤0.01% |
30,500
-8,500
| -22% | -$1.03M |
|
1491
CALL
CRISPR Therapeutics
CRSP
$5.22B
| $3.73M | ﹤0.01% |
71,200
+22,100
| +45% | +$1.32M |
|
|
FRGE
1492
DELISTED
Forge Global Holdings
FRGE
| $3.72M | ﹤0.01% |
+83,487
| New | +$2.82M |
|
1493
CALL
Starbucks
SBUX
$124B
| $3.71M | ﹤0.01% |
44,100
-253,700
| -85% | -$21.4M |
|
1494
CALL
SiriusXM
SIRI
$9.43B
| $3.71M | ﹤0.01% |
185,700
| – | – |
|
1495
Acushnet Holdings
GOLF
$5.25B
| $3.71M | ﹤0.01% |
46,451
-50,767
| -52% | -$4.12M |
|
1496
Pathward Financial
CASH
$1.79B
| $3.68M | ﹤0.01% |
51,892
+45,513
| +713% | +$3.26M |
|
1497
Intuit
INTU
$98B
| $3.68M | ﹤0.01% |
5,561
-8,289
| -60% | -$5.48M |
|
1498
PUT
Iris Energy
IREN
$16B
| $3.67M | ﹤0.01% |
97,200
-452,800
| -82% | -$23.4M |
|
1499
PUT
Zscaler
ZS
$30.4B
| $3.67M | ﹤0.01% |
16,300
+3,300
| +25% | +$931K |
|
1500
PUT
eBay
EBAY
$46.5B
| $3.65M | ﹤0.01% |
41,900
| – | – |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.